Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
OraCoat is a brand of over-the-counter (OTC) oral care products, most notably XyliMelts, developed by Quest Products to manage xerostomia (dry mouth) and oral lesions. The flagship product, XyliMelts, utilizes a patented mucoadhesive disc technology that adheres to the gums or teeth and slowly releases xylitol and oral lubricants. This sustained-release mechanism stimulates natural saliva production and provides a protective coating for the oral mucosa, offering long-lasting relief from dry mouth symptoms, particularly during sleep. Other products in the line include XyliGel for daytime moisture and Renewing Melts for the treatment of canker sores. The brand was originally developed by OraHealth Corporation before being acquired by Quest Products.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on OraCoat.